Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory - |
RCV002260461 | SCV002540082 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2022-06-01 | criteria provided, single submitter | curation | |
Dept of Medical Biology, |
RCV003318410 | SCV004021974 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: PM2, PP2 |
All of Us Research Program, |
RCV004005570 | SCV004817923 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia | 2023-02-24 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with leucine at codon 2683 of the RYR2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RYR2-related disorders in the literature. This variant has been identified in 1/245746 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |